TY - JOUR
T1 - Revising the Diagnosis of Idiopathic Uveitis by Peripheral Blood Transcriptomics
AU - Rosenbaum, James T.
AU - Harrington, Christina A.
AU - Searles, Robert P.
AU - Fei, Suzanne S.
AU - Zaki, Amr
AU - Arepalli, Sruthi
AU - Paley, Michael A.
AU - Hassman, Lynn M.
AU - Vitale, Albert T.
AU - Conrady, Christopher D.
AU - Keath, Puthyda
AU - Mitchell, Claire
AU - Watson, Lindsey
AU - Planck, Stephen R.
AU - Martin, Tammy M.
AU - Choi, Dongseok
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/2
Y1 - 2021/2
N2 - Purpose: To test the hypothesis that idiopathic uveitis can be categorized into subtypes based on gene expression from blood. Design: Case control study. Methods: We applied RNA-Seq to peripheral blood from patients with uveitis associated with 1 of 4 systemic diseases, including axial spondyloarthritis (n = 17), sarcoidosis (n = 13), inflammatory bowel disease (n = 12), tubulo-interstitial nephritis with uveitis (n = 10), or idiopathic uveitis (n = 38) as well as 18 healthy control subjects evaluated predominantly at Oregon Health and Science University. A high-dimensional negative binomial regression model implemented in the edgeR R package compared each disease group with the control subjects. The 20 most distinctive genes for each diagnosis were extracted. Of 80 genes, there were 75 unique genes. A classification algorithm was developed by fitting a gradient boosting tree with 5-fold cross-validation. Messenger RNA from subjects with idiopathic uveitis were analyzed to see if any fit clinically and by gene expression pattern with one of the diagnosable entities. Results: For uveitis associated with a diagnosable systemic disease, gene expression profiling achieved an overall accuracy of 85% (balanced average of sensitivity plus specificity, P <.001). Although most patients with idiopathic uveitis presumably have none of these 4 associated systemic diseases, gene expression profiles helped to reclassify 11 of 38 subjects. Conclusions: Peripheral blood gene expression profiling is a potential adjunct in accurate differential diagnosis of the cause of uveitis. Validation of these results and characterization of the gene expression profile from additional discrete diagnoses could enhance the value of these observations.
AB - Purpose: To test the hypothesis that idiopathic uveitis can be categorized into subtypes based on gene expression from blood. Design: Case control study. Methods: We applied RNA-Seq to peripheral blood from patients with uveitis associated with 1 of 4 systemic diseases, including axial spondyloarthritis (n = 17), sarcoidosis (n = 13), inflammatory bowel disease (n = 12), tubulo-interstitial nephritis with uveitis (n = 10), or idiopathic uveitis (n = 38) as well as 18 healthy control subjects evaluated predominantly at Oregon Health and Science University. A high-dimensional negative binomial regression model implemented in the edgeR R package compared each disease group with the control subjects. The 20 most distinctive genes for each diagnosis were extracted. Of 80 genes, there were 75 unique genes. A classification algorithm was developed by fitting a gradient boosting tree with 5-fold cross-validation. Messenger RNA from subjects with idiopathic uveitis were analyzed to see if any fit clinically and by gene expression pattern with one of the diagnosable entities. Results: For uveitis associated with a diagnosable systemic disease, gene expression profiling achieved an overall accuracy of 85% (balanced average of sensitivity plus specificity, P <.001). Although most patients with idiopathic uveitis presumably have none of these 4 associated systemic diseases, gene expression profiles helped to reclassify 11 of 38 subjects. Conclusions: Peripheral blood gene expression profiling is a potential adjunct in accurate differential diagnosis of the cause of uveitis. Validation of these results and characterization of the gene expression profile from additional discrete diagnoses could enhance the value of these observations.
UR - http://www.scopus.com/inward/record.url?scp=85096391092&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2020.09.012
DO - 10.1016/j.ajo.2020.09.012
M3 - Article
C2 - 32941857
AN - SCOPUS:85096391092
SN - 0002-9394
VL - 222
SP - 15
EP - 23
JO - American journal of ophthalmology
JF - American journal of ophthalmology
ER -